Chinook Therapeutics Inc (KDNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Sales | 3,772 | 3,878 | 3,794 | 38,979 | 4,030 |
| Gross Profit | 3,772 | 3,878 | 3,794 | 38,979 | 4,030 |
| Operating Expenses | 28,982 | 29,019 | 27,740 | 35,722 | 30,063 |
| Operating Income | -25,210 | -25,141 | -23,946 | 3,257 | -26,033 |
| Interest Expense | 0 | 0 | 0 | -520 | -454 |
| Other Income | 646 | 671 | 565 | -9 | -22 |
| Pre-tax Income | -24,564 | -24,470 | -23,381 | 3,768 | -25,601 |
| Income Tax | -2,752 | 5,096 | 11,670 | 1,472 | 3,226 |
| Net Income Continuous | -21,812 | -29,566 | -35,051 | 2,296 | -28,827 |
| Net Income | $-21,812 | $-29,566 | $-35,051 | $2,296 | $-28,827 |
| EPS Basic Total Ops | -1.60 | -2.25 | -2.70 | 0.20 | -2.25 |
| EPS Basic Continuous Ops | -1.60 | -2.22 | -2.69 | 0.18 | -2.26 |
| EPS Diluted Total Ops | -1.60 | -2.20 | -2.70 | 0.15 | -2.25 |
| EPS Diluted Continuous Ops | -1.60 | -2.20 | -2.69 | 0.16 | -2.26 |
| EBITDA(a) | $-23,909 | $-23,865 | $-22,900 | $4,274 | $-24,989 |